Study of Senyo Health App for Bipolar Disorder and Alcohol Use Disorder
This study is looking at how well a digital health app, called Senyo Health, works for people who have both bipolar disorder and alcohol use disorder. The Senyo Health app offers tools like cognitive behavioral therapy (CBT) modules and support from a care manager to help with these conditions. To join, you need to be at least 18 years old, have a diagnosis of bipolar I, bipolar II, or schizoaffective disorder (bipolar type), and also have alcohol use disorder. You should also be able to read and write English and be willing to use a mobile device for communication. The study will measure how easy the app is to use and how well people accept it after 12 weeks. The goal is to see if the app can improve substance use outcomes, like how often and severely someone uses substances, and if they stay in treatment.
- Study design
- This is an interventional study planning to enroll 40 participants. The study type is not specified as randomized or blinded.
- What's involved
- Participants will use a mobile device for asynchronous (text) and synchronous (video) engagement with care. The primary endpoints are measured at 12 weeks.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoints are measured at 12 weeks, which indicates a follow-up period of at least 12 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Senyo Health App - Comorbid Alcohol Use Disorder Treatment in Individuals With Bipolar Disorder Using a Telehealth Collaborative Care Platform
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Mark A. Frye, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
- Tyler S. Oesterle, MD, MPH · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- System Usability Scale (SUS) score12 weeks
The System Usability Scale (SUS) is a 10-item scale to assess usability of the app. Statements are rated on a 5 point scale where 1 = 'strongly disagree' and 5 = 'strongly agree'. Higher total scores indicates higher perception of app usability by patients.
- Acceptability of Intervention Measure (AIM)12 weeks
The Acceptability of Intervention Measure (AIM) is a 12 question survey that assesses acceptability, appropriateness, and feasibility of the app. Responses are on a 5 point scale where 1 = 'completely disagree' and 5 = 'completely agree'. Higher scores indicate greater acceptance of the app.
- Intervention Appropriatness Measure12 weeks
The Intervention Appropriateness Measure (IAM) is a tool consisting of 4 items designed to assess the suitability and relevance of an intervention without specifying a particular purpose, person, or situation. It aims to provide a generalizable assessment of the appropriateness of interventions by capturing individual perspectives on the alignment of the intervention with professional values and perceived efficacy in meeting patient needs.
- Feasibility of Intervention Measure12 weeks
Measuring the feasibility or extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting.
- Timeline Follow BackBaseline, Weekly for 12 weeks, then monthly for 3 months. 9 months and 1 year.
Gather the history of substance use, such as how much you used each day.